Literature DB >> 2518873

pH-profile and regional transit times of the normal gut measured by a radiotelemetry device.

J Fallingborg1, L A Christensen, M Ingeman-Nielsen, B A Jacobsen, K Abildgaard, H H Rasmussen.   

Abstract

The pH of the gut lumen was measured in 39 healthy persons using a pH-sensitive, radiotransmitting capsule. Thirteen persons were studied twice. The location of the capsule was determined by X-ray. The pH rose from 6.4 in the duodenum to 7.3 in the distal part of the small intestine. In 17 persons the pH dropped by 0.1-0.8 pH units during the last hours of the small intestinal transit. The pH was 5.7 in the caecum, but rose to 6.6 in the rectum. Gastric residence time was 1.1 h, small intestinal transit was 8 h, and colonic transit time was 17.5 h (median values). The results provide a firmer basis for prediction of the level, and the rate of release of active substance from pH-dependent sustained-release oral preparations.

Entities:  

Mesh:

Year:  1989        PMID: 2518873     DOI: 10.1111/j.1365-2036.1989.tb00254.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  40 in total

1.  Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease.

Authors:  K Ewe; S Schwartz; S Petersen; A G Press
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

2.  Wireless capsule motility: comparison of the SmartPill GI monitoring system with scintigraphy for measuring whole gut transit.

Authors:  Sabba Maqbool; Henry P Parkman; Frank K Friedenberg
Journal:  Dig Dis Sci       Date:  2009-08-05       Impact factor: 3.199

3.  Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.

Authors:  Valentine C Ibekwe; Hala M Fadda; Emma L McConnell; Mandeep K Khela; David F Evans; Abdul W Basit
Journal:  Pharm Res       Date:  2008-05-09       Impact factor: 4.200

4.  Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.

Authors:  Lida Kalantzi; Konstantinos Goumas; Vasilios Kalioras; Bertil Abrahamsson; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-12-01       Impact factor: 4.200

5.  Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn's disease.

Authors:  J Fallingborg; P Pedersen; B A Jacobsen
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

6.  Characterization of Contents of Distal Ileum and Cecum to Which Drugs/Drug Products are Exposed During Bioavailability/Bioequivalence Studies in Healthy Adults.

Authors:  Christos Reppas; Eleni Karatza; Constantinos Goumas; Constantinos Markopoulos; Maria Vertzoni
Journal:  Pharm Res       Date:  2015-05-22       Impact factor: 4.200

7.  Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.

Authors:  Rajkumar Malayandi; Phani Krishna Kondamudi; P K Ruby; Deepika Aggarwal
Journal:  Drug Deliv Transl Res       Date:  2014-04       Impact factor: 4.617

8.  Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes.

Authors:  Felix Stader; Marco Siccardi; Manuel Battegay; Hannah Kinvig; Melissa A Penny; Catia Marzolini
Journal:  Clin Pharmacokinet       Date:  2019-04       Impact factor: 6.447

Review 9.  An integrative view of microbiome-host interactions in inflammatory bowel diseases.

Authors:  Marta Wlodarska; Aleksandar D Kostic; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

Review 10.  Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs.

Authors:  S G Nugent; D Kumar; D S Rampton; D F Evans
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.